| Literature DB >> 31277922 |
Toshifumi Tada1, Hiroko Iijima2, Natsuko Kobayashi3, Masahiro Yoshida4, Takashi Nishimura5, Takashi Kumada6, Reiichiro Kondo7, Hirohisa Yano7, Masayoshi Kage8, Chikage Nakano4, Tomoko Aoki4, Nobuhiro Aizawa9, Naoto Ikeda9, Tomoyuki Takashima9, Yukihisa Yuri9, Noriko Ishii9, Kunihiro Hasegawa9, Ryo Takata9, Kazunori Yoh9, Yoshiyuki Sakai9, Hiroki Nishikawa9, Yoshinori Iwata9, Hirayuki Enomoto9, Seiichi Hirota10, Jiro Fujimoto11, Shuhei Nishiguchi9.
Abstract
We investigated the diagnostic capability of the proprietary attenuation imaging (ATI) modality found on some Canon Medical Systems Corp. ultrasound scanners to detect histologically diagnosed steatosis in 148 patients. ATI values increased significantly with increasing steatosis grade (p < 0.001). The diagnostic values (area under the receiver operating characteristic curve) of ATI for steatosis grades ≥ 1 (5%-33% of hepatocytes), ≥ 2 (33%-66% of hepatocytes) and 3 (> 66% of hepatocytes) were 0.85, 0.91 and 0.91. In addition, ATI values increased significantly with increasing steatosis grades (p = 0.002) even in obese patients (n = 41). The diagnostic values of ATI for steatosis grades ≥ 1, ≥ 2 and 3 in obese patients were 0.72, 0.72 and 0.78. Furthermore, ATI values increased significantly with increasing steatosis grade (p < 0.001) in patients with non-alcoholic fatty liver disease (NAFLD) (n = 38). The diagnostic values of ATI for steatosis grades ≥ 1, ≥ 2 and 3 in NAFLD patients were 0.77, 0.88 and 0.86. In conclusion, the ATI method showed good diagnostic capability for the detection of hepatic steatosis.Entities:
Keywords: Attenuation imaging; Hepatic steatosis; Ultrasound
Mesh:
Year: 2019 PMID: 31277922 DOI: 10.1016/j.ultrasmedbio.2019.05.033
Source DB: PubMed Journal: Ultrasound Med Biol ISSN: 0301-5629 Impact factor: 2.998